13D/13G Filings - Lynwood Capital Management Inc.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-14
4:35 pm
Purchase
2022-12-31 13G BriaCell Therapeutics Corp.
BCTX
Lynwood Capital Management Inc. 97,333
9.300%
39,333increase
(+67.82%)
Filing
History
2022-08-01
07:00 am
Purchase
2022-07-20 13G BriaCell Therapeutics Corp.
BCTX
Lynwood Capital Management Inc. 58,000
5.600%
5,667increase
(+10.83%)
Filing
History
2022-02-11
08:00 am
Sale
2021-12-31 13G BriaCell Therapeutics Corp.
BCTX
Lynwood Capital Management Inc. 52,333
4.920%
-6,333decrease
(-10.80%)
Filing
History
2021-08-17
4:04 pm
Purchase
2021-08-09 13G BriaCell Therapeutics Corp.
BCTX
Lynwood Capital Management Inc. 58,667
5.800%
58,667increase
(New Position)
Filing
History